Overview

DBT and Escitalopram in Borderline Personality Disorder

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Subjects will receive six months of DBT, consisting of one 90-minute group and one 60-minute individual session per week as well as telephone availability of the individual therapist. Half the subjects will concurrently receive escitalopram while half will receive placebo, in a randomized double-blind design.
Phase:
N/A
Details
Lead Sponsor:
Bronx VA Medical Center
Treatments:
Citalopram
Dexetimide